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doi:10.1016/j.gmbhs.2011.08.002Abstract Efavirenz is commonly used as part of the highly active antiretroviral therapy
(HAART) for the treatment of human immunodeficiency virus (HIV) type 1. The effects of
chronic administration of efavirenz on the kidney of adult Wistar rats were investigated.
The rats were divided into two groups, those given efavirenz (treatment) and those given
water (control), both for 30 days. The animals were sacrificed by cervical dislocation on Day
31 of the experiment and kidneys were dissected, weighed and quickly fixed in 10% formalin
for histological analysis. The findings indicate that there was a significant (p < 0.05) decrease
in weight and increase in relative weight of treated right and left kidneys compared to the
control group. Kidneys in the treated group showed disruption of the cytoarchitecture of
the renal cortical structure, diffuse glomerulonephritis with some cell congestion, and dilation
of Bowman’s space compared to the control group. Chronic efavirenz administration may
therefore have an adverse effect on the kidney function of adult Wistar rats. Further studies
to corroborate these observations should be carried out.
Copyright ª 2011, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Efavirenz is a non-nucleoside reverse transcriptase inhibitor
(NNRTI) used as part of highly active antiretroviral therapyof Anatomy, School of Basic
P.M.B 1154, Benin City, Edo
om (J.O. Adjene).
an Genomic Medicine and Bioma(HAART) for the treatment of human immunodeficiency
virus (HIV) type 1.1 Efavirenz is effective in many combi-
nation regimes for the treatment of HIV infection, both in
previously untreated and in treated individuals. It has been
combined successfully with nucleosides such as lamivudine
or emtricitabine plus abacavir, didanosine, stavidine,
tenofovir or zidovudine to achieve virologic suppression in
a high percentage of recipients.2,3 Most antiviral agents do
not efficiently penetrate the bloodebrain barrier (BBB) or
are actively transported out of the central nervous systemrker Society. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1 Mean  SEM kidney weight and relative weight
for the animals.
Control
(n Z 10)
Treatment
(n Z 10)
Body weight (g) *260  30.19 *197  15.85
Right kidney weight (g) *0.58  0.14 *0.50  0.18
Relative right kidney
weight (%)
*0.23  0.07 *0.25  0.07
Left kidney weight (g) *0.56  0.19 *0.48  0.06
Relative left kidney
weight (%)
*0.22  0.09 *0.25  0.01
*Significant (p < 0.05).
Effects of efavirenz on rat kidney 77(CNS).4 Even after antiviral treatment that successfully
controls the virus in the treatment compartments, the CNS
may suffer continuing damage induced by HIV infection.5
Efavirenz may be taken once a day without regard to
meals and it can penetrate the CNS and spinal fluid.6,7
Adverse effects on the CNS have been associated with
efavirenz.8 The most common CNS effects include confu-
sion, insomnia, abnormal vivid dreams, dizziness and
headache. Efavirenz has emerged as the cornerstone of
HAART regimens. The side effect profile of the drug is
generally regarded as satisfactory. However, there are
conflicting study results in the literature and conflicting
evidence from patients and physicians regarding neuro-
psychiatric problems associated with efavirenz.9 Lipodys-
trophy, moderate or severs pain, abnormal vision,
arthralgia. asthenia, dyspnea, gynecomastia, myalgia,
myopathy and tinnitus have all been reported on efavirenz
use.1
The kidney is a paired organ located in the posterior
abdominal wall. Its functions include removal of waste
metabolic products from the blood and regulation of water
and electrolyte balance in the body. In humans, the
majority of drugs are eliminated via a combination of
hepatic metabolism and renal excretion.10 Since the kidney
is involved in the excretion of many toxic metabolic waste
products, particularly nitrogenous compounds, it would be
worthwhile to examine the effects of efavirenz adminis-
tration on the kidney. The aim of this study was to inves-
tigate the morphological effects of chronic efavirenz
administration on the kidney of adult Wistar rats.
Materials and methods
Animals
Twenty adult Wistar rats of both sexes with an average
weight of 200 g were randomly assigned to two groups:
a control group (n Z 10) and a treatment group (n Z 10).
The rats were obtained from and maintained in the Animal
Holding of the Department of Anatomy, School of Basic
Medical Sciences, University of Benin (Benin City, Edo
State, Nigeria). They were fed with grower’s mash obtained
from Edo Feeds and Flour Mill Limited (Ewu, Edo State,
Nigeria) and had ad libitum access to water. Efavirenz was
obtained from the President Emergency Plan for AIDS Relief
(PEPFAR) Unit, University of Benin Teaching Hospital (Benin
City, Edo State, Nigeria).
Drug administration and sample preparation
Rats in the treatment group received the recommended
efavirenz dosage of 600 mg/70 kg body weight dissolved in
distilled water via orogastric tube administration for
30 days. The control rats received an equal volume of
distilled water via the same route for the same period. The
rats were sacrificed by cervical dislocation on Day 31 of the
experiment. The abdomen was quickly opened to expose
the kidneys, which were quickly dissected out, dried,
weighed on a Mettler Toledo balance and fixed in 10%
formalin for histological analysis. Laboratory chemicals
were obtained from May and Baker (Dagenham, UK).Histological analysis
Tissues were dehydrated in an ascending ethanol gradient,
cleared in xylene and embedded in paraffin wax. Serial
sections of 7 mm in thickness were obtained using a rotatory
microtome. Deparaffinized sections were stained with
hematoxylin and eosin.11 Photomicrographs of the sections
were taken using a photographic microscope (Olympus,
Tokyo, Japan) in the Department of Anatomy, School of
Basic Medical Sciences, University of Benin.Statistical analysis
Mean values for control and treatment group kidneys were
recorded and compared statistically using the paired-
sample t test and symmetric measured test of the Statis-
tical Package for Social Sciences (SPSS Inc., Chicago, IL,
USA).Results
For the right kidney, the mean weight was 0.58 g and 0.50 g
and the relative weight was 0.23% and 0.25% in the control
and treatment groups, respectively. For the left kidney, the
mean weight was 0.56 g and 0.48 g and the relative weight
was 0.22% and 0.25% in the control and treatment groups,
respectively. Thus, there was a significant (p < 0.05)
decrease in weight and an increase in relative weight of
right and left kidneys in the treatment group compared to
the control group (Table 1, Fig. 1). This is as a result of the
programmed cell death that occurs when kidney cells die
on activation of an internal suicide program. This in turn
results in morphologic cellular shrinkage that leads to
a significant decrease in kidney weight.
The photomicrograph of a kidney from the control group
shows normal histological features. A detailed cortical
parenchyma is evident and renal corpuscles appeared as
dense rounded structures, with the glomerulus surrounded
by a narrow Bowman’s space (Fig. 2). Kidneys in the
treatment group showed a level of distortion and disruption
of the cytoarchitecture of the renal cortical structure,
diffuse glomerulonephritis, and some cell congestion and
dilated Bowman’s space compared to the control group
(Fig. 3).
Figure 1 Bar charts showing mean  SEM for (A) right kidney weight, (B) relative right kidney weight, (C) left kidney weight and
(D) relative left kidney weight of the animals.
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There was a significant decrease in kidney weight and
increase in relative weight in the treatment group
compared to the control group. Kidneys in the treatment
group showed a level of distortion and disruption of the
cytoarchitecture of the renal cortical structure, diffuse
glomerulonephritis and some cell congestion compared to
the control group.
The results obtained are probably due to the effects of
chronic efavirenz administration on the kidney. Thus,
chronic efavirenz administration may not be as harmless as
generally believed. The distortion and disruption of kidney
cytoarchitecture observed here may have been associatedFigure 2 Photomicrographs of a control kidney section at mag
G Z glomerulus.with functional changes that could be detrimental to the
health status of the animals. The significant decrease in
kidney weight and increase in relative weight compared to
the control group might be due to a cytotoxic effect of
efavirenz on the kidney. As tissue swells or shrinks, as
observed in this study, the activity of cellular transporters
is up- or downregulated, as reported for hyponatramia and
hypernatremia. 12Ischemia or pharmacologic disruption of
cellular transporters can cause parenchymal swelling in any
organ. Pharmacologic disruption of kidney weight caused by
efavirenz is the cardinal feature of the results of this study.
There are many different causes of cell swelling or
shrinkage, including drug poisoning, water intoxication,
hypoxia and acute hyponatremia.12 Under such conditions,nification of (A) 100 and (B) 400. B Z Bowman’s space;
Figure 3 Microanatomy (hematoxylin and eosin staining) of a treated kidney section at magnification of (A) 100 and (B) 400.
A Z diffuse glomerulonephritis; B Z dilated Bowman’s space; C Z distortion and disruption of the glomerulus; D Z cell
congestion.
Effects of efavirenz on rat kidney 79there is a net shift of water from the extracellular space to
the cell interior.12 The significant decrease in weight and
significant increase in relative weight of the kidney
observed in this study usually involve intracellular swelling
or shrinkage of the endothelia.12
The obvious signs of diffuse glomerulonephritis and
dilated Bowman’s space observed in this study may have
been due to cytotoxic effects of efavirenz on the kidney.
These findings implicate efavirenz as a possible precipitant
of kidney disease by causing congestion of kidney cells.
Pathological or accidental cell death is regarded as necrotic
and could result from extrinsic insults to the cell such as
osmotic, thermal, toxic and traumatic effects.13 Cellular
necrosis involves disruption of membranes, as well as
structural and functional integrity. It is not induced by
stimuli intrinsic to cells, as in programmed cell death, but
by an abrupt environmental perturbation and departure
from normal physiological conditions.14 The rate of
progression of cellular necrosis depends on the severity of
the environmental insult. The greater the severity of the
insult, the more rapid is progression of neuronal injury.15
This principle holds true for toxicological insult to the
brain and other organs.14 It may be inferred from the
present study that prolonged efavirenz administration
resulted in increased toxic effects on the kidney. The
results are in accordance with work carried out by Enaibe
et al16 who reported that camphor administration resulted
in mild edema with glomerulonephritis, glomerular lobula-
tion, tubular necrosis and congestion of blood cells in rabbit
kidney. It has been reported that damiana (Turnera diffusa)
administration to mature Wistar rats resulted in distortion
of the renal cortical structure, reduced the size and
number of renal corpuscles, and led to a degree of cellular
necrosis in the kidney.17 In the present study, efavirenz may
have acted as a toxin to the cells of the kidney, causing
distortion and disruption, cell congestion, dilated Bow-
man’s space and glomerulonephritis in renal cortical
structures. The results are in line with a study that reported
that chronic consumption of soda drinks resulted in varying
degrees of distortion and disruption of the cytoarchitectureof the renal cortical structure, diffuse glomerulonephritis
with some congestion and tubular necrosis in adult Wistar
rats compared to controls.18Conclusions
Our study revealed that chronic efavirenz administration
resulted in distortion and disruption of kidney cytoarchi-
tecture compared to control kidneys. Cell congestion and
glomerulonephritis were also observed in treated kidneys.
These results indicate that kidney function may be
adversely affected by chronic efavirenz treatment. Further
studies to corroborate these findings should be carried out.References
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